Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2000 Feb;59(2):120–124. doi: 10.1136/ard.59.2.120

Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature

B Kovacs 1, T Lafferty 1, L Brent 1, R DeHoratius 1
PMCID: PMC1753077  PMID: 10666167

Abstract

OBJECTIVE—To give a comprehensive review of transverse myelopathy (TM), a rare but serious condition reported in 1-2% of patients with systemic lupus erythematosus (SLE).
METHODS—14 patients with SLE and TM were evaluated and 91 additional cases published in the English and German literature reviewed.
RESULTS—TM presented either as the initial manifestation or within five years of the diagnosis of SLE. Most patients presented with a detectable sensory deficit at the thoracic level. In our 14 patients, 22% of the patients showed complete neurological recovery, whereas in the total patient population of 105 (our cases plus those reviewed in the literature), complete recovery was observed in 50%, partial recovery in 29% and no improvement or deterioration in 21%. Treatment with intravenous methylprednisolone followed by cyclophosphamide seemed to be most effective. Seventy per cent of the total patient population had abnormal magnetic resonance imaging findings. In our group of 14 patients, those with higher disease activity (measured by the SLAM) at onset of TM were treated more aggressively (for example, with plasmapheresis and intravenous pulse cyclophosphamide). TM in our patients was associated with antiphospholipid antibodies in 43% of the cases as compared with 64% of the total patient population. Optic neuritis occurred in 48% of the total patient population with SLE and TM, suggesting an association.
CONCLUSIONS—TM in SLE is a poorly understood entity. Outcome might be more favourable than previously suggested. There is an association of TM with antiphospholipid antibodies in SLE patients. Treatment including intravenous cyclophosphamide may improve the final outcome. This report emphasises the need for multicentre trials to establish guidelines for optimal treatment.



Full Text

The Full Text of this article is available as a PDF (137.8 KB).

Figure 1  .

Figure 1  

Open in a new tab

MRI from one of our patients (patient 2) showing increased signal intensity of the mid to lower thoracic spinal cord and atrophy (attenuation) of the spinal cord.    

Figure 2  .

Figure 2  

Open in a new tab

MRI results compared with outcome. Data from patients with an abnormal MRI (n=39) are shown in black columns, those of patients with a normal MRI (n=16) in gray columns.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón-Segovia D., Delezé M., Oria C. V., Sánchez-Guerrero J., Gómez-Pacheco L., Cabiedes J., Fernández L., Ponce de León S. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989 Nov;68(6):353–365. doi: 10.1097/00005792-198911000-00003. [DOI] [PubMed] [Google Scholar]
  2. Allen I. V., Millar J. H., Kirk J., Shillington R. K. Systemic lupus erythematosus clinically resembling multiple sclerosis and with unusual pathological and ultrastructural features. J Neurol Neurosurg Psychiatry. 1979 May;42(5):392–401. doi: 10.1136/jnnp.42.5.392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andrianakos A. A., Duffy J., Suzuki M., Sharp J. T. Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature. Ann Intern Med. 1975 Nov;83(5):616–624. doi: 10.7326/0003-4819-83-5-616. [DOI] [PubMed] [Google Scholar]
  4. April R. S., Vansonnenberg E. A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Clinicopathologic report and review of the literature. Neurology. 1976 Nov;26(11):1066–1070. doi: 10.1212/wnl.26.11.1066. [DOI] [PubMed] [Google Scholar]
  5. Baca V., Lavalle C., García R., Catalán T., Sauceda J. M., Sánchez G., Martínez I., Ramírez M. L., Márquez L. M., Rojas J. C. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol. 1999 Feb;26(2):432–439. [PubMed] [Google Scholar]
  6. Barile L., Lavalle C. Transverse myelitis in systemic lupus erythematosus--the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol. 1992 Mar;19(3):370–372. [PubMed] [Google Scholar]
  7. Berlanga B., Rubio F. R., Moga I., Pac V. Response to intravenous cyclophosphamide treatment in lupus myelopathy. J Rheumatol. 1992 May;19(5):829–830. [PubMed] [Google Scholar]
  8. Berman M., Feldman S., Alter M., Zilber N., Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology. 1981 Aug;31(8):966–971. doi: 10.1212/wnl.31.8.966. [DOI] [PubMed] [Google Scholar]
  9. Boumpas D. T., Patronas N. J., Dalakas M. C., Hakim C. A., Klippel J. H., Balow J. E. Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol. 1990 Jan;17(1):89–92. [PubMed] [Google Scholar]
  10. Chan K. F., Boey M. L. Transverse myelopathy in SLE: clinical features and functional outcomes. Lupus. 1996 Aug;5(4):294–299. doi: 10.1177/096120339600500409. [DOI] [PubMed] [Google Scholar]
  11. Cordeiro M. F., Lloyd M. E., Spalton D. J., Hughes G. R. Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 1994 Sep;57(9):1142–1143. doi: 10.1136/jnnp.57.9.1142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cuadrado M. J., Tinahones F., Camps M. T., de Ramon E., Gómez-Zumaquero J. M., Mujic F., Khamashta M. A., Hughes G. R. Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome. QJM. 1998 Sep;91(9):619–626. doi: 10.1093/qjmed/91.9.619. [DOI] [PubMed] [Google Scholar]
  13. Deodhar A. A., Hochenedel T., Bennett R. M. Longitudinal involvement of the spinal cord in a patient with lupus related transverse myelitis. J Rheumatol. 1999 Feb;26(2):446–449. [PubMed] [Google Scholar]
  14. Gibson T. P., Dibona G. F. Use of the American Rheumatism Association's preliminary criteria for the classification of systemic lupus erythematosus. Ann Intern Med. 1972 Nov;77(5):754–756. doi: 10.7326/0003-4819-77-5-754. [DOI] [PubMed] [Google Scholar]
  15. Hardie R. J., Isenberg D. A. Tetraplegia as a presenting feature of systemic lupus erythematosus complicated by pulmonary hypertension. Ann Rheum Dis. 1985 Jul;44(7):491–493. doi: 10.1136/ard.44.7.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Harisdangkul V., Doorenbos D., Subramony S. H. Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol. 1995 May;242(5):326–331. doi: 10.1007/BF00878876. [DOI] [PubMed] [Google Scholar]
  17. Jabs D. A., Miller N. R., Newman S. A., Johnson M. A., Stevens M. B. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol. 1986 Apr;104(4):564–568. doi: 10.1001/archopht.1986.01050160120026. [DOI] [PubMed] [Google Scholar]
  18. Kenik J. G., Krohn K., Kelly R. B., Bierman M., Hammeke M. D., Hurley J. A. Transverse myelitis and optic neuritis in systemic lupus erythematosus: a case report with magnetic resonance imaging findings. Arthritis Rheum. 1987 Aug;30(8):947–950. doi: 10.1002/art.1780300818. [DOI] [PubMed] [Google Scholar]
  19. Kinney E. L., Berdoff R. L., Rao N. S., Fox L. M. Devic's syndrome and systemic lupus erythematosus: a case report with necropsy. Arch Neurol. 1979 Oct;36(10):643–644. doi: 10.1001/archneur.1979.00500460077012. [DOI] [PubMed] [Google Scholar]
  20. Kira J., Goto I. Recurrent opticomyelitis associated with anti-DNA antibody. J Neurol Neurosurg Psychiatry. 1994 Sep;57(9):1124–1125. doi: 10.1136/jnnp.57.9.1124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Klaiman M. D., Miller S. D. Transverse myelitis complicating systemic lupus erythematosus: treatment including hydroxychloroquine. Case report. Am J Phys Med Rehabil. 1993 Jun;72(3):158–161. doi: 10.1097/00002060-199306000-00010. [DOI] [PubMed] [Google Scholar]
  22. Lavalle C., Pizarro S., Drenkard C., Sánchez-Guerrero J., Alarcón-Segovia D. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol. 1990 Jan;17(1):34–37. [PubMed] [Google Scholar]
  23. Liang M. H., Socher S. A., Larson M. G., Schur P. H. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989 Sep;32(9):1107–1118. doi: 10.1002/anr.1780320909. [DOI] [PubMed] [Google Scholar]
  24. Marabani M., Zoma A., Hadley D., Sturrock R. D. Transverse myelitis occurring during pregnancy in a patient with systemic lupus erythematosus. Ann Rheum Dis. 1989 Feb;48(2):160–162. doi: 10.1136/ard.48.2.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Misteli M., Conen D. Akute Querschnittsmyelitis bei systemischem Lupus erythematodes: erfolgreiche Therapie mit Cyclophosphamid und Prednison. Schweiz Med Wochenschr. 1991 Jan 19;121(3):77–80. [PubMed] [Google Scholar]
  26. Mok C. C., Lau C. S., Chan E. Y., Wong R. W. Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol. 1998 Mar;25(3):467–473. [PubMed] [Google Scholar]
  27. Neuwelt C. M., Lacks S., Kaye B. R., Ellman J. B., Borenstein D. G. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med. 1995 Jan;98(1):32–41. doi: 10.1016/S0002-9343(99)80078-3. [DOI] [PubMed] [Google Scholar]
  28. O'Riordan J. I., Gallagher H. L., Thompson A. J., Howard R. S., Kingsley D. P., Thompson E. J., McDonald W. I., Miller D. H. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):382–387. doi: 10.1136/jnnp.60.4.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Propper D. J., Bucknall R. C. Acute transverse myelopathy complicating systemic lupus erythematosus. Ann Rheum Dis. 1989 Jun;48(6):512–515. doi: 10.1136/ard.48.6.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Radis C. D., Callis K. P. Systemic lupus erythematosus with membranous glomerulonephritis and transverse myelitis associated with anabolic steroid use. Arthritis Rheum. 1997 Oct;40(10):1899–1902. doi: 10.1002/art.1780401027. [DOI] [PubMed] [Google Scholar]
  31. Rodríguez A. S., Oterino J. A., Hernandez P. A. Lupus myelitis. Arch Intern Med. 1998 Nov 9;158(20):2267–2268. doi: 10.1001/archinte.158.20.2267. [DOI] [PubMed] [Google Scholar]
  32. Salmaggi A., Lamperti E., Eoli M., Venegoni E., Bruzzone M. G., Riccio G., La Mantia L. Spinal cord involvement and systemic lupus erythematosus: clinical and magnetic resonance findings in 5 patients. Clin Exp Rheumatol. 1994 Jul-Aug;12(4):389–394. [PubMed] [Google Scholar]
  33. Sands M. L., Ryczak M., Brown R. B. Recurrent aseptic meningitis followed by transverse myelitis as a presentation of systemic lupus erythematosus. J Rheumatol. 1988;15(5):862–864. [PubMed] [Google Scholar]
  34. Satoh A., Suzuki K., Takayama E., Kojima K., Hidaka T., Kawakami M., Matsumoto I., Ohsuzu F. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol. 1999 Aug;26(8):1715–1720. [PubMed] [Google Scholar]
  35. Schantz V., Oestergaard L. L., Junker P. Shrinking spinal cord following transverse myelopathy in a patient with systemic lupus erythematosus and the phospholipid antibody syndrome. J Rheumatol. 1998 Jul;25(7):1425–1428. [PubMed] [Google Scholar]
  36. Simeon-Aznar C. P., Tolosa-Vilella C., Cuenca-Luque R., Jordana-Comajuncosa R., Ordi-Ros J., Bosch-Gil J. A. Transverse myelitis in systemic lupus erythematosus: two cases with magnetic resonance imaging. Br J Rheumatol. 1992 Aug;31(8):555–558. doi: 10.1093/rheumatology/31.8.555. [DOI] [PubMed] [Google Scholar]
  37. Smyth A. E., Bruce I. N., McMillan S. A., Bell A. L. Transverse myelitis: a complication of systemic lupus erythematosus that is associated with the antiphospholipid syndrome. Ulster Med J. 1996 May;65(1):91–94. [PMC free article] [PubMed] [Google Scholar]
  38. Szer I. S., Miller J. H., Rawlings D., Shaham B., Bernstein B. Cerebral perfusion abnormalities in children with central nervous system manifestations of lupus detected by single photon emission computed tomography. J Rheumatol. 1993 Dec;20(12):2143–2148. [PubMed] [Google Scholar]
  39. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  40. Tartaglino L. M., Croul S. E., Flanders A. E., Sweeney J. D., Schwartzman R. J., Liem M., Amer A. Idiopathic acute transverse myelitis: MR imaging findings. Radiology. 1996 Dec;201(3):661–669. doi: 10.1148/radiology.201.3.8939212. [DOI] [PubMed] [Google Scholar]
  41. Tola M. R., Casetta I., Granieri E., Caniatti L. M., Monetti V. C., Pascarella R. Systemic lupus erythematosus related recurrent transverse myelitis in a patient with myasthenia gravis and multiple sclerosis. Eur Neurol. 1996;36(5):327–328. doi: 10.1159/000117285. [DOI] [PubMed] [Google Scholar]
  42. Tola M. R., Granieri E., Caniatti L., Paolino E., Monetti C., Dovigo L., Scolozzi R., De Bastiani P., Carreras M. Systemic lupus erythematosus presenting with neurological disorders. J Neurol. 1992 Feb;239(2):61–64. doi: 10.1007/BF00862972. [DOI] [PubMed] [Google Scholar]
  43. Valesini G., Priori R., Francia A., Balestrieri G., Tincani A., Airo P., Cattaneo R., Zambruni A., Troianello B., Chofflon M. Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate. Springer Semin Immunopathol. 1994;16(2-3):313–321. doi: 10.1007/BF00197524. [DOI] [PubMed] [Google Scholar]
  44. Warren R. W., Kredich D. W. Transverse myelitis and acute central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum. 1984 Sep;27(9):1058–1060. doi: 10.1002/art.1780270915. [DOI] [PubMed] [Google Scholar]
  45. West S. G. Lupus and the central nervous system. Curr Opin Rheumatol. 1996 Sep;8(5):408–414. doi: 10.1097/00002281-199609000-00004. [DOI] [PubMed] [Google Scholar]
  46. West S. G. Neuropsychiatric lupus. Rheum Dis Clin North Am. 1994 Feb;20(1):129–158. [PubMed] [Google Scholar]
  47. Zerbini C. A., Fidelix T. S., Rabello G. D. Recovery from transverse myelitis of systemic lupus erythematosus with steroid therapy. J Neurol. 1986 Jun;233(3):188–189. doi: 10.1007/BF00314433. [DOI] [PubMed] [Google Scholar]
  48. Zivelin A., Gitel S., Griffin J. H., Xu X., Fernandez J. A., Martinowitz U., Cohen Y., Halkin H., Seligsohn U., Inbal A. Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C. Blood. 1999 Aug 1;94(3):895–901. [PubMed] [Google Scholar]
  49. de Brum-Fernandes A. J., Lucena-Fernandes M. F., Levy Neto M., Cossermelli W. Myelitis in systemic lupus erythematosus. Arthritis Rheum. 1987 Feb;30(2):238–239. doi: 10.1002/art.1780300225. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES